196 related articles for article (PubMed ID: 30302639)
1. ASO Author Reflections: Contact Between T and N Classifications in Pancreatic Neuroendocrine Neoplasms.
Xu JZ; Wang WQ; Liu L; Yu XJ
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):814-815. PubMed ID: 30302639
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors.
Gaitanidis A; Patel D; Kebebew E
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):874-875. PubMed ID: 30353397
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors.
Massironi S; Rossi RE
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):858-859. PubMed ID: 30145647
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors.
Lopez-Aguiar AG; Cardona K
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):826-827. PubMed ID: 30456670
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms.
Nanno Y; Toyama H
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):800-801. PubMed ID: 30136123
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Accuracy of Grading in Pancreatic Neuroendocrine Neoplasms and Effect on Survival Estimates: An Institutional Experience.
Trikalinos NA; Chatterjee D
Ann Surg Oncol; 2020 Sep; 27(9):3551-3552. PubMed ID: 32253674
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors.
Cloyd JM; Poultsides GA
Ann Surg Oncol; 2021 Feb; 28(2):1050-1051. PubMed ID: 32974698
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Lymph Node Metastasis in Pancreatic Neuroendocrine Tumor.
Tanaka M; Hackert T
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):863-864. PubMed ID: 32720037
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Simplifying the Fundamentals of Gastric Neuroendocrine Tumor Management.
Sok C; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1519-1520. PubMed ID: 38123732
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Role of the Computed Tomography Maximum in Pancreatic Neuroendocrine Tumors.
Chen H; Ji S
Ann Surg Oncol; 2023 May; 30(5):2999. PubMed ID: 36305988
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Preoperative Malignant Risk Assessment for Small (≤ 20 mm) Nonfunctioning Pancreatic Neuroendocrine Tumors.
Nanno Y; Toyama H
Ann Surg Oncol; 2023 Jun; 30(6):3501-3502. PubMed ID: 36765011
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors-A Single Operation is Feasible in Most Patients.
Gudmundsdottir H; Halfdanarson TR; Cleary SP
Ann Surg Oncol; 2022 Oct; 29(11):6958-6959. PubMed ID: 35780453
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Circulating Neuroendocrine Gene Transcripts (NETest): A Promising Biomarker for Pancreatic Neuroendocrine Tumours (PanNET).
Partelli S; Falconi M
Ann Surg Oncol; 2020 Oct; 27(10):3937-3938. PubMed ID: 32462530
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms.
Zhang Q; Wang Y; Liang T
Ann Surg Oncol; 2022 Nov; 29(12):7631. PubMed ID: 35794367
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Uninsurance is Associated with Worse Outcomes Following Resection for Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Marincola Smith P; Baechle JJ; Idrees K
Ann Surg Oncol; 2020 Sep; 27(9):3154-3155. PubMed ID: 32189167
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors.
Zhang N; Zhang XF; Pawlik TM
Ann Surg Oncol; 2024 May; 31(5):2973-2974. PubMed ID: 38142259
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Patient-Reported Quality of Life in Patients with Neuroendocrine Tumors Following Surgical Resection.
Rosowicz A; Bangla VG; Divino CM
Ann Surg Oncol; 2023 Oct; 30(11):6786. PubMed ID: 37394669
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Cytoreduction for Extrahepatic Metastatic Neuroendocrine Tumors.
Chan DL; Hallet J
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):866-867. PubMed ID: 30306370
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Outcomes of Gastroesophageal Neuroendocrine Tumors.
Gray KD; Zarnegar R
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):868-869. PubMed ID: 30421041
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases.
Tran Cao HS; Vauthey JN
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):792-793. PubMed ID: 30334195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
